We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Stellar Biotechnologies, Inc. (MM) | NASDAQ:SBOT | NASDAQ | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 1.05 | 1.06 | 1.08 | 0 | 01:00:00 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549
FORM 8-K CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
|
On July 6, 2016, Stellar Biotechnologies, Inc. (the Company) closed its previously announced $6.75 million registered direct offering of 1,687,500 common shares, no par value (the Common Shares) and concurrent private placement of warrants to purchase up to 1,265,626 Common Shares (the Warrants). In connection with the offering and private placement, the Company entered into a Securities Purchase Agreement with four institutional investors, each dated June 30, 2016. The combined purchase price for one registered Common Share and one Warrant to purchase 0.75 of an unregistered Common Share was $4.00.
Item 9.01. Financial Statements and Exhibits
(d) Exhibits
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
|
Dated: July 06, 2016
|
STELLAR BIOTECHNOLOGIES, INC.
By:
/s/ Kathi Niffenegger
|
|
|
Exhibit No. | Description |
99.1 | Press Release of Stellar Biotechnologies, Inc. dated July 06, 2016 |
1 Year Stellar Biotechnologies Inc. Chart |
1 Month Stellar Biotechnologies Inc. Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions